The global laboratory animal model market is witnessing steady expansion, driven by the increasing demand for preclinical research and biomedical innovation. The market is projected to grow at a CAGR of 8.1% during 2025–2031, reflecting the rising importance of animal models in drug discovery and disease research.
Laboratory animal models—including mice, rats, rabbits, and guinea pigs—play a crucial role in understanding disease mechanisms and evaluating the safety and efficacy of new drugs. These models are widely used across pharmaceutical, biotechnology, and academic research sectors, making them indispensable in modern healthcare advancements.
The increasing complexity of diseases and the need for innovative treatment approaches are further strengthening the demand for advanced animal models. As a result, the market is expected to witness sustained growth through 2031, supported by technological advancements and expanding research activities.
Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00025691
Key Market Drivers Accelerating Growth
Increasing Demand for Drug Discovery and Development
One of the primary drivers of the laboratory animal model market is the growing focus on drug discovery and development. Pharmaceutical and biotechnology companies are heavily investing in preclinical studies to develop new therapies for complex diseases.
Laboratory animal models are essential for testing drug safety, efficacy, and toxicity before human clinical trials. With the increasing pipeline of novel drugs—especially in oncology, neurology, and immunology—the demand for reliable and high-quality animal models is rising significantly.
Rising Prevalence of Chronic Diseases
The global increase in chronic diseases such as cancer, diabetes, cardiovascular disorders, and neurological conditions is another major growth driver. These diseases require extensive research to understand their progression and develop effective treatments.
Animal models play a critical role in studying disease mechanisms and identifying therapeutic targets. As the prevalence of chronic illnesses continues to rise worldwide, the need for laboratory animal models is expected to grow correspondingly.
Advancements in Biotechnology and Personalized Medicine
Rapid advancements in biotechnology, including gene editing, stem cell research, and personalized medicine, are significantly driving the market. Technologies such as CRISPR have enabled the development of genetically modified animal models that closely mimic human diseases.
These models are essential for precision medicine, where treatments are tailored to individual genetic profiles. The growing adoption of personalized healthcare approaches is creating strong demand for specialized animal models, further boosting market growth.
Increasing Government and Private Funding for Research
Government bodies and private organizations across the globe are increasing investments in biomedical research. Funding initiatives aimed at combating chronic and infectious diseases are encouraging the use of laboratory animal models in scientific studies.
Such financial support is enabling research institutions and pharmaceutical companies to expand their R&D capabilities. As funding for life sciences research continues to grow, it is expected to drive the adoption of laboratory animal models significantly.
Emergence of Humanized and Genetically Modified Models
The development of humanized animal models is transforming biomedical research. These models incorporate human genes, tissues, or immune systems, providing more accurate insights into human diseases and drug responses.
Additionally, genetically modified models, including transgenic and knockout animals, are gaining popularity for studying gene functions and disease pathways. These innovations are enhancing the predictive value of preclinical studies and driving market growth.
Growth in Outsourcing of Preclinical Research
The increasing trend of outsourcing research to contract research organizations (CROs) is another key driver of the laboratory animal model market. CROs offer specialized expertise in handling animal studies, enabling pharmaceutical companies to focus on core business operations.
As more companies adopt outsourcing strategies to reduce costs and improve efficiency, the demand for laboratory animal models is expected to rise. This trend is contributing to the expansion of the market globally.
Regional Insights
North America holds a dominant share in the laboratory animal model market, supported by strong research infrastructure, high healthcare expenditure, and the presence of leading pharmaceutical companies. Europe also represents a significant market due to increasing research activities and regulatory support.
The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Rising investments in healthcare infrastructure, expanding pharmaceutical industries, and increasing research initiatives in countries such as China and India are driving regional market growth.
Competitive Landscape and Key Players
The laboratory animal model market is highly competitive, with several key players focusing on innovation, strategic collaborations, and expansion of research capabilities. Prominent companies operating in the market include:
- Charles River Laboratories International, Inc.
- Envigo
- Eurofins Scientific
- genOway
- Hera Biolabs
- JSR Life Sciences, LLC (Crown Bioscience International)
- Ozgene Pty Ltd.
- PerkinElmer (Horizon Discovery Ltd.)
- Taconic Biosciences, Inc.
These companies are actively investing in advanced technologies and expanding their global presence to strengthen their market position.
Future Outlook
The global laboratory animal model market is poised for significant growth through 2031, driven by increasing research activities, technological advancements, and the rising prevalence of chronic diseases. The integration of genetic engineering and personalized medicine is expected to further enhance the relevance of animal models in biomedical research.
Despite challenges related to ethical concerns and the development of alternative testing methods, the market continues to evolve with innovations that improve efficiency and accuracy. With a projected CAGR of 8.1%, the laboratory animal model market is set to remain a cornerstone of life sciences research and drug development.
Top Trending Reports:
Animal Care Services Market Analysis, Regional and Competitive Landscape Forecast by 2031
Laboratory Equipment Services Market Opportunities, Forecast, Size, Analysis till 2031
Laboratory Developed Test Market Size Trends & Key Opportunities 2034
About Us
The Insight Partners is a leading global market research and consulting firm that provides actionable insights across various industries, including healthcare, life sciences, and technology. Our reports are designed to help organizations make informed decisions by offering comprehensive market analysis, trends, and forecasts.
Contact Us
The Insight Partners
Email: sales@theinsightpartners.com
Phone: +1-646-491-9876
Website: www.theinsightpartners.com
Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek